If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 66   2005   NUMBER 7

Editorial

816 Focus on Alzheimer's Disease and Related Disorders. Eric M. Reiman
[PDF]

Commentary

818 The Texas Implementation of Medication Algorithms Update for Treatment of Bipolar I Disorder. Roy H. Perlis and Paul E. Keck, Jr.
[PDF]

Original Articles

821 Psychiatric Genetics: A Survey of Psychiatrists' Knowledge, Opinions, and Practice Patterns. Christine T. Finn, Marsha A. Wilcox, Bruce R. Korf, Deborah Blacker, Stephanie R. Racette, Pamela Sklar, and Jordan W. Smoller
[Abstract] [PDF]

831 Quality of Life in Schizophrenia: A Multicenter, Randomized, Naturalistic, Controlled Trial Comparing Olanzapine to First-Generation Antipsychotics. Maurício Silva de Lima, Jair de Jesus Mari, Alan Breier, Anna Maria Costa, Eduardo Pondé de Sena, and Matthew Hotopf
[Abstract] [PDF]

839 Double-Blind, Placebo-Controlled Study of Modafinil for Fatigue and Cognition in Schizophrenia Patients Treated With Psychotropic Medications. Serge Sevy, Murray H. Rosenthal, Jose Alvir, Sabina Meyer, Hema Visweswaraiah, Handan Gunduz-Bruce, and Nina R. Schooler
[Abstract] [PDF]

844 A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction. Charles DeBattista, Brent Solvason, Jennifer Poirier, Ellen Kendrick, and Emily Loraas
[Abstract] [PDF]

849 The Clinical Domains of Psychosomatic Medicine. [CME] Giovanni A. Fava and Nicoletta Sonino
[Abstract] [PDF]

859 What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors? Koen Demyttenaere, Adelin Albert, Patrick Mesters, Walthère Dewè, Katrien De Bruyckere, and Michèle Sangeleer
[Abstract] [PDF]

864 Severe Obsessive-Compulsive Disorder With and Without Comorbid Hair Pulling: Comparisons and Clinical Implications. [CME] S. Evelyn Stewart, Michael A. Jenike, and Nancy J. Keuthen
[Abstract] [PDF]

870 The Texas Implementation of Medication Algorithms: Update to the Algorithms for Treatment of Bipolar I Disorder. Trisha Suppes, Ellen B. Dennehy, Robert M. A. Hirschfeld, Lori L. Altshuler, Charles L. Bowden, Joseph R. Calabrese, M. Lynn Crismon, Terence A. Ketter, Gary S. Sachs, and Alan C. Swann, for the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder
[Abstract] [PDF]

887 Risperidone Dosing Pattern and Clinical Outcome in Psychosis: An Analysis of 1713 Cases. Chang Yoon Kim, Yong-Wook Shin, Yeon Ho Joo, Jin-Pyo Hong, Gun Hee Lee, and Sung-Ku Choi
[Abstract] [PDF]

894 Predictors for the Efficacy of Electroconvulsive Therapy: Chart Review of a Naturalistic Study. King Han Kho, Aeilko H. Zwinderman, and Ben A. Blansjaar
[Abstract] [PDF]

900 Diabetes Mellitus Among Outpatients Receiving Clozapine: Prevalence and Clinical-Demographic Correlates. J. Steven Lamberti, G. Oana Costea, David Olson, John F. Crilly, Kumar Maharaj, Xin Tu, Adrienne Groman, Marci B. Dietz, Margaret P. Bushey, Telva Olivares, and Karen Wiener
[Abstract] [PDF]

907 Abnormal Regional Cerebral Blood Flow in Systemic Lupus Erythematosus Patients With Psychiatric Symptoms. Kenji Oda, Eisuke Matsushima, Yoshiro Okubo, Katsuya Ohta, Yuji Murata, Ryuji Koike, Nobuyuki Miyasaka, and Motoichiro Kato
[Abstract] [PDF]

914 Optimizing the Detection of Bipolar II Disorder in Outpatient Private Practice: Toward a Systematization of Clinical Diagnostic Wisdom. Hagop S. Akiskal and Franco Benazzi
[Abstract] [PDF]

922 Risperidone in Psychotic Combat-Related Posttraumatic Stress Disorder: An Open Trial. Dragica Kozarić-Kovacić, Nela Pivac, Dorotea Mück-Seler, and Barbara Olasov Rothbaum
[Abstract] [PDF]

928 A Retrospective Study of the Safety of Intramuscular Ziprasidone in Agitated Elderly Patients. K. Elizabeth Greco, Larry E. Tune, Frank W. Brown, and William A. Van Horn
[Abstract] [PDF]

930 Add-On rTMS for Medication-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial in Chinese Patients. Tung-Ping Su, Chih-Chia Huang, and I-Hua Wei
[Abstract] [PDF]

Focus on Alzheimer's Disease and Related Disorders

938 In This Issue: Genetics, Cholesterol, and the Risk of Alzheimer's Disease. Eric M. Reiman
[PDF]

940 A Cluster of Cholesterol-Related Genes Confers Susceptibility for Alzheimer's Disease. Andreas Papassotiropoulos, M. Axel Wollmer, Magdalini Tsolaki, Fabienne Brunner, Dimitra Molyva, Dieter Lütjohann, Roger M. Nitsch, and Christoph Hock
[Abstract] [PDF]

ASCP Corner

948 Challenges and Opportunities in Teaching Psychopharmacology During Residency Training. Sidney Zisook, Ira Glick, and David A. Goldberg
[PDF]

Letters To the Editor

949 Allergic Reaction to Depot Risperidone but Not to Oral Risperidone. Roy R. Reeves and James E. Mack
[PDF]

949 Relapsing Paranoid Psychosis as the First Manifestation of Pheochromocytoma. Antoni Benabarre, Xavier Bosch, Maria T. Plana, Albert Lecube, Eduard Vieta, Esteve Cirera, and Manuel Valdés
[PDF]

950 Weight Gain and Antipsychotics. Paul Mackin ˇ Reply by John M. Kane
[PDF]

951 Increasing Energy Expenditure Is Important to Enhance Management of Antipsychotic-Associated Weight Gain. Jenny-Kay Sharpe, Terry J. Stedman, Nuala M. Byrne, and Andrew P. Hills ˇ Reply by Rohan Ganguli and Jaspreet S. Brar
[PDF]

Book Reviews 953